| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| Guideline-for-Assess..> | 2023-04-03 11:56 | 1.3M | ||
| Guideline-for-Emerge..> | 2023-04-03 11:54 | 1.0M | ||
| Guideline-for-contro..> | 2023-04-03 11:52 | 1.0M | ||
| Pharmacovigilance-ne..> | 2023-04-24 12:46 | 799K | ||
| Pharmacovigilance-ne..> | 2023-04-24 12:47 | 680K | ||
| Guidelines-on-Relian..> | 2023-04-25 16:55 | 537K | ||
| Pharmacovigilance-ne..> | 2023-04-24 12:41 | 472K | ||
| Brochure-Medsafety-m..> | 2023-04-27 11:05 | 340K | ||
| Brochure-MDR-medicin..> | 2023-04-27 11:10 | 200K | ||
| Brochure-COVID-19-Co..> | 2023-04-27 11:09 | 175K | ||
| Pfizer-Vaccine-Broch..> | 2023-04-27 11:02 | 100K | ||